Clinical Trial Update: Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of talazoparib in Asian patients with metastatic breast cancer characterized by homologous recombination defici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: University of Malaya | Conditions: HRD 100 Gene Expression High, Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN